Hormone Therapies

In women with type 2 diabetes, the changes in sex-hormone levels, abdominal fat, and insulin metabolism that accompany menopause may represent additional impediments in achieving good glycaemic control. There is evidence that exogenous estrogens might reduce some of these adverse changes.

    Related Conference of Hormone Therapies

    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK
    July 11-12, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Hormone Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in